Saltar al contenido
Merck
  • Synthesis of potential Rho-kinase inhibitors based on the chemistry of an original heterocycle: 4,4-dimethyl-3,4-dihydro-1H-quinolin-2-one.

Synthesis of potential Rho-kinase inhibitors based on the chemistry of an original heterocycle: 4,4-dimethyl-3,4-dihydro-1H-quinolin-2-one.

European journal of medicinal chemistry (2008-01-01)
Marie-Anne Letellier, Jérôme Guillard, Daniel-Henri Caignard, Gilles Ferry, Jean A Boutin, Marie-Claude Viaud-Massuard
RESUMEN

A new series of substituted 4,4-dimethyl-3,4-dihydro-1H-quinolin-2-one have been prepared via condensation of 3,3-dimethylacryloyl chloride with aniline. Details of synthetic procedures are shown. Our aim was to investigate the potency of our original heterocycle in the inhibition of the Rho-kinase enzyme, known to be of major importance in the cascade reactions leading to arterial hypertension. Biological activity for the seven compounds has been investigated and is presented.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
3,3-Dimethylacryloyl chloride, 97%, contains 400 ppm phenothiazine as inhibitor